Opinions expressed by Entrepreneur contributors are their very own.
Key insights
- Healthspan is targeted on improving quality of life, not only quality of life, driving the longevity market’s projected growth to $8 trillion by 2030.
- Preventive health and evidence-based solutions are transforming the health economics and require significant investment from consumers and businesses.
- The longevity sector is attracting institutional investment and mainstream attention, indicating a structural shift in global healthcare and capital markets.
The longevity space is taking off, and for entrepreneurs and investors seeking to construct in emerging sectors, this evolution in health and wellness represents probably the most significant opportunities of the last decade.
According to a UBS report As of March 2025, the longevity market is predicted to grow from $5.3 trillion in 2023 to $8 trillion in 2030, even surpassing AI, which is predicted to achieve $1.16 trillion by 2027 Longevity economicsThe biggest gap is in healthspan, the years wherein we live in good health and freed from chronic disease.
Here are five things founders and VCs need to grasp.
Sign up for the Entrepreneur Daily newsletter to get the news and resources it’s good to run your online business higher today. Get it in your inbox.
1. The real opportunity lies in health expectancy, not only life expectancy
As populations within the United States, Europe and Asia proceed to age, demand is shifting from simply extending life to improving the standard of life. By 2050, greater than 2 billion people worldwide shall be over 60, and within the United States, adults over 65 are expected to make up nearly 1 / 4 of the population in the following decade.
Still World Health Organization data from 2024 shows a roughly decade-long gap between the common global life expectancy of 71.4 years and the health expectancy of 61.9 years. Scientific American repeated this in 2025, noting that while lifespans have improved, The health span has remained largely unchanged. Closing this nearly decade-long gap is each a public health imperative and a industrial opportunity.
The World Economic Forum 2025 report on Future-proofing the Longevity Economy highlights that aging populations are transforming labor markets, financial systems and consumer demand worldwide, positioning healthcare innovation as an economic infrastructure moderately than a distinct segment healthcare category.
During the 2026 Annual Meeting of the World Economic Forum in DavosHealthy aging and preventative health were embedded in broader discussions about labor force participation, long-term growth and financial sustainability, reinforcing longevity as an economic priority moderately than a selected health issue.
2. Prevention changes health economics
The shift toward proactive and preventive health is gaining momentum, particularly within the United States, where chronic diseases account for the vast majority of healthcare spending. Consumers are increasingly willing to speculate earlier in solutions that support metabolic health, mobility, cognitive performance and overall resilience, moderately than waiting for late-stage medical interventions.
The rapid adoption of GLP-1 therapies within the United States has further accelerated this shift by redefining metabolic health as modifiable and shifting each consumer expectations and capital allocation toward preventive models.
UBS forecasts annual growth of 5% to 7% in sectors linked to the healthcare industry, including lively and medical nutrition, dietary supplements, consumer health and wellness technology. Even adjoining industries reminiscent of beauty, hospitality and travel are seeing average annual growth of 4.5% to six.3% as they align their offerings with a longevity-focused lifestyle. This just isn’t a distinct segment consumption trend, but moderately a comprehensive realignment of consumer spending.
3. Corporate strategies are already positioning themselves
Large established firms are taking decisive motion. Unilever has expanded its wellness portfolio through acquisitions including Onnit and OLLY to expand its commitment to preventive health and lifestyle-related longevity.
For VCs, this signals greater than just consumer appetite. It provides credible exit routes as strategic buyers assemble longevity-focused portfolios. Healthspan is being integrated into mainstream corporate strategy and isn’t any longer limited to specialized biotech circles.
4. Evidence will separate winners from the noise
As capital flows into the sector, scientific credibility will increasingly determine long-lasting firms. Evidence-based innovation, clinical validation and measurable results will differentiate long-term platforms from marketing-driven wellness brands.
Founders constructing Healthspan must work closely with researchers, scientists and practitioners and integrate data collection and real-world validation into their models from the beginning. In an environment that pulls attention and speculation, rigor becomes a competitive advantage.
5. Longevity shifts from boundary conditions to institutional features
The global concentrate on longevity is increasing. The Global Healthspan Summit 2023 in Riyadh was the primary international meeting of its kind, bringing together founders, investors and researchers to shape the longer term of the sector. Conversations that after occurred on the fringes of biotech and wellness at the moment are central to capital allocation and long-term healthcare strategy.
Longevity and health care have also been recurring topics recently JP Morgan Healthcare ConferencesThis reflects how entrenched the conversation is in mainstream healthcare investing.
This capital shift is measurable. Longevity investment greater than doubled in 2024 to about $8.5 billion across 325 deals, with later-stage enterprise capital accounting for a few third of total funding, signaling growing institutional confidence within the sector.
With the market expected to achieve $8 trillion by 2030, longevity isn’t any longer a problem. It reflects a structural shift in the best way aging populations, health systems and capital markets take into consideration value creation.
For founders and VCs working in health, longevity, wellness or consumer technology, it is a rare convergence of scale and impact. The opportunity lies not only in extending life, but in addition in redefining the best way those extra years are lived.
Do you ought to buy a franchise but do not know where to begin? Entrepreneur Franchise Advisors guide you thru the method from start to complete – freed from charge. Register here.
Key insights
- Healthspan is targeted on improving quality of life, not only quality of life, driving the longevity market’s projected growth to $8 trillion by 2030.
- Preventive health and evidence-based solutions are transforming the health economics and require significant investment from consumers and businesses.
- The longevity sector is attracting institutional investment and mainstream attention, indicating a structural shift in global healthcare and capital markets.
The longevity space is taking off, and for entrepreneurs and investors seeking to construct in emerging sectors, this evolution in health and wellness represents probably the most significant opportunities of the last decade.
According to a UBS report As of March 2025, the longevity market is predicted to grow from $5.3 trillion in 2023 to $8 trillion in 2030, even surpassing AI, which is predicted to achieve $1.16 trillion by 2027 Longevity economicsThe biggest gap is in healthspan, the years wherein we live in good health and freed from chronic disease.
